Net income of $28.9 million on $154.5 million in revenue, compared to net income of $30.6 million on $189.0 million in revenue in Q2 2024 ...

This news release constitutes a designated news release for the purposes of the Company's amended and restated prospectus ...

Shares end little changed as miners offset banks. Gold miners rally on US jitters. Endeavour rallies after chair quits. Beach ...

As India sets its sights on a USD 35 trillion future by 2047, the real engine of growth will not just be factories or exports ...

Clorox delivered a substantial beat on both revenue (GAAP) and adjusted EPS (non-GAAP) in Q4 FY2025, primarily due to a one-time boost from ERP-related shipments. Underlying consumer demand and ...

Today, Sarah Cole speaks with ISN Editor Riad Beladi about the current trends in the retail technology market. She shares insights into what retailers and supermarkets are prioritising, and offers ...

Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has expanded its existing relationship and amended ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in ...

At a time when the word genocide is being used with political motive, and defencive war is being misconstrued as genocide and real and most brutal genocide is taking place on a global scale with ...

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...